335 related articles for article (PubMed ID: 26752703)
1. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
Di Lena M; Porcelli F; Altomare DF
Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
[TBL] [Abstract][Full Text] [Related]
2. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
[TBL] [Abstract][Full Text] [Related]
3. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
[TBL] [Abstract][Full Text] [Related]
4. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
[TBL] [Abstract][Full Text] [Related]
5. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer.
Bond A; Greenwood R; Lewis S; Corfe B; Sarkar S; O'Toole P; Rooney P; Burkitt M; Hold G; Probert C
Aliment Pharmacol Ther; 2019 Apr; 49(8):1005-1012. PubMed ID: 30828825
[TBL] [Abstract][Full Text] [Related]
6. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.
van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH
Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079
[TBL] [Abstract][Full Text] [Related]
7. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
Sun X; Shao K; Wang T
Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP).
Mozdiak E; Wicaksono AN; Covington JA; Arasaradnam RP
Tech Coloproctol; 2019 Apr; 23(4):343-351. PubMed ID: 30989415
[TBL] [Abstract][Full Text] [Related]
9. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
Oakley-Girvan I; Davis SW
Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
[TBL] [Abstract][Full Text] [Related]
10. Volatile organic compounds analysis as a potential novel screening tool for colorectal cancer: A systematic review and meta-analysis.
Zhou W; Tao J; Li J; Tao S
Medicine (Baltimore); 2020 Jul; 99(27):e20937. PubMed ID: 32629696
[TBL] [Abstract][Full Text] [Related]
11. Breath testing as potential colorectal cancer screening tool.
Amal H; Leja M; Funka K; Lasina I; Skapars R; Sivins A; Ancans G; Kikuste I; Vanags A; Tolmanis I; Kirsners A; Kupcinskas L; Haick H
Int J Cancer; 2016 Jan; 138(1):229-36. PubMed ID: 26212114
[TBL] [Abstract][Full Text] [Related]
12. Breath analysis for colorectal cancer screening.
Altomare DF
Colorectal Dis; 2016 Dec; 18(12):1127-1128. PubMed ID: 27507419
[No Abstract] [Full Text] [Related]
13. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
14. Systematic review with meta-analysis: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer.
Chandrapalan S; Bosch S; Cubiella J; Guardiola J; Kimani P; Mulder C; Persaud K; de Meij TGJ; Altomare DF; Brenner H; de Boer NKH; Ricciardiello L; Arasaradnam RP
Aliment Pharmacol Ther; 2021 Jul; 54(1):14-23. PubMed ID: 34004036
[TBL] [Abstract][Full Text] [Related]
15. VOC breath biomarkers in lung cancer.
Saalberg Y; Wolff M
Clin Chim Acta; 2016 Aug; 459():5-9. PubMed ID: 27221203
[TBL] [Abstract][Full Text] [Related]
16. A novel non-invasive colorectal cancer diagnostic method: Volatile organic compounds as biomarkers.
Alustiza M; Ripoll L; Canals A; Murcia O; Martínez-Roca A; García-Heredia A; Giner-Calabuig M; Jover R; Vidal L
Clin Chim Acta; 2023 Mar; 542():117273. PubMed ID: 36863694
[TBL] [Abstract][Full Text] [Related]
17. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
[TBL] [Abstract][Full Text] [Related]
18. Exhaled breath analysis by electronic nose in respiratory diseases.
Scarlata S; Pennazza G; Santonico M; Pedone C; Antonelli Incalzi R
Expert Rev Mol Diagn; 2015; 15(7):933-56. PubMed ID: 25959642
[TBL] [Abstract][Full Text] [Related]
19. Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.
Hanna GB; Boshier PR; Markar SR; Romano A
JAMA Oncol; 2019 Jan; 5(1):e182815. PubMed ID: 30128487
[TBL] [Abstract][Full Text] [Related]
20. Urine as a biological modality for colorectal cancer detection.
Chandrapalan S; Arasaradnam RP
Expert Rev Mol Diagn; 2020 May; 20(5):489-496. PubMed ID: 32130868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
